Jorge David Aivazoglou Carneiro

Author

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo ORCID

Also Known As

Carneiro, Jorge David Aivazoglou, J. Carneiro, J. D. A. Carneiro, J.D.A. Carneiro, JORGE DAVID AIVAZOGLOU CARNEIRO, Jorge Carneiro, Jorge D. A. Carneiro, Jorge D.A. Carneiro, Jorge David A. Carneiro, Jorge David Aivazoglou Carneiro

Publications

641

Citations

H-Index

Concepts

All Affiliations

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Hospital for Sick Children Universidade de São Paulo Laurentian University Fundação Pró-Sangue Hemocentro de São Paulo

About

Jorge David Aivazoglou Carneiro is an author at Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo specializing in medicine, hematology, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	170
2	Education	1	1	14
3	Health Sciences	1	1	12
4	Language Studies	1	1	14
5	Child Development	1	1	14

Jorge David Aivazoglou Carneiro

Publications

461

Citations

H-Index

Page 1

	Year	Citations
Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial Leonardo R. Brandão, Matteo Luciani, Lisa Bomgaars, The Lancet Haematology ThrombosisVenous DiseaseVenous ThrombosisDabigatran EtexilateVenous Disease Treatment	2020	134
Characterization of vitamin K–dependent carboxylase mutations that cause bleeding and nonbleeding disorders Jian‐Ke Tie, Jorge David Aivazoglou Carneiro, Da-Yun Jin, Blood	2016	57
Persistent symptoms and decreased health-related quality of life after symptomatic pediatric COVID-19: A prospective study in a Latin American tertiary hospital Thais T. Fink, Heloísa Helena de Sousa Marques, Bruno Gualano, Clinics	2021	51
Hematological findings in Noonan syndrome Débora Romeo Bertola, Jorge David Aivazoglou Carneiro, Élbio Antônio D’Amico, Revista do Hospital das Clínicas	2003	38
Comparing the burden of illness of haemophilia between resource‐constrained and unconstrained countries: the São Paulo–Toronto Hemophilia Study Jorge David Aivazoglou Carneiro, V. Blanchette, Margareth C. Ozelo, Haemophilia	2017	27
Episodic replacement of clotting factor concentrates does not prevent bleeding or musculoskeletal damage – the <scp>MUSFIH</scp> study Pradeep Mathew Poonnoose, Jorge David Aivazoglou Carneiro, Anne-Louise Cruickshank, Haemophilia	2017	25
Impact of prophylaxis on health‐related quality of life of boys with hemophilia: An analysis of pooled data from 9 countries Koyo Usuba, Victoria Price, Victor S. Blanchette, Research and Practice in Thrombosis and Haemostasis	2019	22
Joint lavage followed by viscosupplementation and triamcinolone in patients with severe haemophilic arthropathy: objective functional results Márcia Uchôa de Rezende, Félix Ricardo Andrusaitis, R. T. Silva, Haemophilia	2016	15
Process and experience of cross-cultural adaptation of a quality of life measure (CHO-KLAT) for boys with haemophilia in Brazil Paula Ribeiro Villaça, Jorge David Aivazoglou Carneiro, Élbio Antônio D’Amico, Haemophilia Quality Of LifeFamily MedicineHealth-related QualitySão PauloEducation	2013	14
Hypopituitarism, Deficiency of Factors V and VIII and von Willebrand Factor: An Uncommon Association Nuvarte Setian, Clarice Tanaka, Daniel Damiani, Journal of Pediatric Endocrinology and Metabolism Clinical DisordersVon Willebrand FactorBlood Coagulation AbnormalitiesPhysiologyGenetic Epidemiology	2002	12

Page 1